These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6382251)

  • 21. Serum concentration and urinary elimination of ethambutol administered alone and in combination with rifampin in patients of pulmonary tuberculosis.
    Singhal KC; Rathi R; Kishore K; Varshney SC; Varshney DP
    J Indian Med Assoc; 1986 Dec; 84(12):376-8. PubMed ID: 3585015
    [No Abstract]   [Full Text] [Related]  

  • 22. [Rifampicin and ethambutol in treating chronic destructive pulmonary tuberculosis].
    Roslik SM; Iakovleva LM; Zhitnaia VI; Grushevskiĭ ES; Poluianova RP
    Probl Tuberk; 1980 Jun; (6):30-3. PubMed ID: 7393907
    [No Abstract]   [Full Text] [Related]  

  • 23. Tuberculosis in renal transplant recipients.
    Tantawichien T; Suwangool P; Suvanapha R
    Transplant Proc; 1994 Aug; 26(4):2187-8. PubMed ID: 8066715
    [No Abstract]   [Full Text] [Related]  

  • 24. [L-transformation of the mycobacterial population in the process of treating patients with newly detected destructive pulmonary tuberculosis].
    Khomenko AG; Karachunskiĭ MA; Dorozhkova IR; Chukanov VI; Balta IuE
    Probl Tuberk; 1980 Feb; (2):18-23. PubMed ID: 6769110
    [No Abstract]   [Full Text] [Related]  

  • 25. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
    Wang JY; Lee LN; Yu CJ; Chien YJ; Yang PC;
    Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neutralization of the sputum in newly detected patients with pulmonary tuberculosis treated during the years 1967 to 1970].
    Panajotović H; Marsenić B
    Plucne Bolesti Tuberk; 1974; 26 Suppl 2():105-9. PubMed ID: 4216916
    [No Abstract]   [Full Text] [Related]  

  • 27. [Efficiency of an intensive stage of chemotherapy for tuberculosis in elderly and senile patients].
    Karachunskiĭ MA; Uvarova TE
    Probl Tuberk Bolezn Legk; 2004; (3):19-21. PubMed ID: 15338894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rifampicin--a leading drug in the therapy of tuberculosis not easily amenable to treatment.
    Tousek J
    Respiration; 1971; 28():Suppl:116-22. PubMed ID: 5150791
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficiency of short-course tuberculosis chemotherapy in controlled clinical trials and in programme conditions in Romania.
    Anastasatu C; Corlan E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):133-9. PubMed ID: 2999949
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effectiveness of abbreviated biphasic treatment in pulmonary tuberculosis].
    Cramer G
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(3):177-80. PubMed ID: 6273990
    [No Abstract]   [Full Text] [Related]  

  • 31. [The problem of infectiousness of tuberculosis patients during chemotherapy].
    Schulthess HK; Zollikofer H
    Schweiz Med Wochenschr; 1981 Feb; 111(8):251-4. PubMed ID: 6785880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) II. Side effects].
    Girling DJ
    Bull Int Union Tuberc; 1974; 49(1):451-5. PubMed ID: 4619567
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evolution of the treatment of tuberculosis].
    Grassi C
    Minerva Med; 1984 Mar; 75(11):569-72. PubMed ID: 6709194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Is the combination of INH and RFP always bactericidal? An observation in programme condition--report of the B series of 20th Controlled Trial of Chemotherapy (author's transl)].
    Kekkaku; 1980 Apr; 55(4):207-14. PubMed ID: 6993746
    [No Abstract]   [Full Text] [Related]  

  • 37. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
    Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627
    [No Abstract]   [Full Text] [Related]  

  • 38. [Dynamics of the release of bacilli and the closing of caverns in newly identified tuberculosis patients undergoing different chemotherapeutic regimens].
    Muratov VV; Pashkov IuN; Pospelov VV
    Probl Tuberk; 1981 Dec; (12):30-4. PubMed ID: 6801646
    [No Abstract]   [Full Text] [Related]  

  • 39. [Long-term observation of pulmonary Mycobacterium avium complex disease treated with chemotherapy-- following the guidelines for treatment].
    Kobashi Y; Oka M
    Kekkaku; 2008 Dec; 83(12):779-84. PubMed ID: 19172823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Rifampicin in the treatment of newly detected adolescent pulmonary tuberculosis patients].
    Ganiev KG; Esanbaev DE; Kirina SB
    Probl Tuberk; 1983 May; (5):42-6. PubMed ID: 6866983
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.